Global Self-Monitoring Blood Glucose System Market Size By Type (Blood Glucose Test Strips, Blood Glucose Meter), By Application (Hospital, Household), By Region, And Segment Forecasts, 2023 to 2032

The Global Self-Monitoring Blood Glucose (SMBG) System Market was valued at USD 9.3 billion in 2023 and is projected to reach USD 16.8 billion by 2031, expanding at a CAGR of 7.5% during the forecast period of 2023–2031. The growth is primarily driven by the escalating prevalence of diabetes worldwide, increasing patient awareness, and the growing demand for personalized and real-time glucose monitoring solutions. SMBG systems enable individuals to track their blood glucose levels accurately, facilitating timely treatment decisions and better diabetes management, thereby reducing long-term complications and healthcare costs.

Drivers:

Rising Global Prevalence of Diabetes:

The surging number of type 1 and type 2 diabetes cases globally is a significant driver for the SMBG market. According to the International Diabetes Federation, over 530 million adults were living with diabetes in 2023, a number expected to rise considerably in the coming years.

Shift Toward Home-Based Healthcare:

The growing inclination toward at-home health management tools is increasing the demand for compact, user-friendly SMBG systems. These devices empower patients to independently monitor their blood sugar levels and improve adherence to treatment regimens.

Technological Advancements:

Innovations such as continuous data syncing with mobile apps, cloud-based monitoring, and integration with insulin pumps are significantly enhancing user experience and healthcare provider accessibility, thus propelling market growth.

Restraints:

High Cost of Devices and Consumables:

The recurring cost of test strips, lancets, and advanced glucometers may burden low-income patients, particularly in emerging economies, limiting widespread adoption.

Accuracy Concerns and Calibration Issues:

Inaccurate readings due to user errors, strip inconsistencies, or calibration challenges can affect treatment decisions, posing a constraint to the market’s reliability and trustworthiness.

Opportunity:

Integration with Digital Health Ecosystems:

The convergence of SMBG systems with digital health tools, electronic health records, and telemedicine platforms presents vast opportunities to create a connected and holistic diabetes management ecosystem.

Untapped Potential in Emerging Markets:

Developing countries, particularly in Asia-Pacific and Latin America, present immense growth potential driven by rising healthcare investments, increasing diabetes awareness, and expanding access to diagnostic technologies.

Market by System Type Insights:

Based on system type, the Blood Glucose Meters segment held the largest market share in 2023. These meters remain the most common self-monitoring tools due to their cost-efficiency and ease of use. However, the Continuous Glucose Monitoring (CGM)-linked systems are gaining rapid traction and are expected to record the fastest growth rate through 2031. The CGM systems provide real-time glucose readings, trend patterns, and predictive alerts, making them highly valuable for intensive diabetes management.

Market by End-Use Insights:

In terms of end use, the Home Care segment emerged as the largest revenue generator in 2023, accounting for over 55% of the market share. The rising preference for managing chronic conditions from the comfort of one’s home is driving this segment’s growth. Additionally, Hospitals & Clinics are also expanding their SMBG capabilities to support remote monitoring, pre-surgical assessments, and acute care diagnostics.

Market by Regional Insights:

Geographically, North America dominated the global SMBG market in 2023, fueled by high diabetes prevalence, advanced healthcare infrastructure, and strong reimbursement frameworks. Asia-Pacific, on the other hand, is projected to witness the fastest growth during the forecast period. Factors such as rapid urbanization, increasing disposable income, and a growing elderly population are contributing to heightened diabetes diagnosis and treatment rates in countries like China and India.

Competitive Scenario:

Key players operating in the Global Self-Monitoring Blood Glucose System Market include:

Abbott Laboratories

F. Hoffmann-La Roche Ltd

Ascensia Diabetes Care Holdings AG

Dexcom, Inc.

LifeScan, Inc.

Medtronic plc

Sanofi

B. Braun Melsungen AG

Terumo Corporation

ARKRAY, Inc.

These companies are investing in product innovation, AI-based glucose tracking, mobile connectivity, and strategic partnerships to expand their market presence. For instance:

In 2024, Abbott introduced an upgraded version of its FreeStyle Libre system, with extended wear time and improved mobile integration.

Dexcom partnered with multiple healthcare providers to deploy its CGM systems in chronic care management platforms.

In 2023, Ascensia Diabetes Care launched a new blood glucose monitoring system featuring Bluetooth connectivity and real-time analytics.

Scope of Work – Global Self-Monitoring Blood Glucose System Market

Report Metric Details

Market Size (2023) USD 9.3 billion

Projected Market Size (2031) USD 16.8 billion

CAGR (2023–2031) 7.5%

Market Segments By System Type (Glucometers, CGMs), By End-Use (Homecare, Hospitals)

Growth Drivers Rising diabetes prevalence, home-based healthcare adoption, tech advancements

Opportunities Emerging market expansion, digital health integration

Key Market Developments:

January 2024: Abbott announced FDA clearance for its next-generation CGM device with extended wear up to 21 days.

August 2023: Dexcom launched a CGM platform compatible with multiple smart insulin pens and digital therapeutics.

March 2023: Medtronic received CE marking for its hybrid CGM-pump integration system aimed at type 1 diabetes patients in Europe.

FAQs:

1) What is the current market size of the Global Self-Monitoring Blood Glucose System Market?

The market was valued at USD 9.3 billion in 2023.

2) What is the major growth driver of the Global Self-Monitoring Blood Glucose System Market?

The increasing global prevalence of diabetes and the rising demand for home-based glucose monitoring are key drivers.

3) Which is the largest region during the forecast period in the Global Self-Monitoring Blood Glucose System Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow at the fastest pace.

4) Which segment accounted for the largest market share in the Global Self-Monitoring Blood Glucose System Market?

The Blood Glucose Meters segment held the largest share in 2023.

5) Who are the key market players in the Global Self-Monitoring Blood Glucose System Market?

Major players include Abbott, Dexcom, F. Hoffmann-La Roche, Ascensia Diabetes Care, and LifeScan.

Let me know if you would like this description formatted into a Word document or adapted for a specific platform.